Clinical Trial Update: A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 study evaluating the safety and exploratory efficacy of KTP-001 in subjects with lumbar disc herniation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Herniation

Drugs mentioned

• KTP-001

Snippet

Sponsor: Teijin America, Inc. | Conditions: Lumbar Disc Herniation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-05